Cargando…

Biodegradable porous polymeric drug as a drug delivery system: alleviation of doxorubicin-induced cardiotoxicity via passive targeted release

Doxorubicin (DOX) is an effective chemotherapeutic drug developed against a broad range of cancers, and its clinical applications are greatly restricted by the side effects of severe cardiotoxicity during tumour treatment. Herein, the DOX-loaded biodegradable porous polymeric drug, namely, Fc-Ma-DOX...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiao, Qiuhong, Liu, Baoting, Xu, Xiufeng, Huang, Tao, Cao, Bufan, Wang, Lide, Wang, Qingguo, Du, Ailing, Li, Jingtian, Zhou, Baolong, Wang, Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Royal Society of Chemistry 2023
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9923820/ https://www.ncbi.nlm.nih.gov/pubmed/36793291 http://dx.doi.org/10.1039/d2ra07410a

Ejemplares similares

Utilizing Network Pharmacology and Molecular Docking Integrated Surface Plasmon Resonance Technology to Investigate the Potential Targets and Mechanisms of Tripterygium wilfordii against Pulmonary Artery Hypertension
por: Wang, Shifa, et al.
Publicado: (2022)

Mechanisms and Drug Intervention for Doxorubicin-Induced Cardiotoxicity Based on Mitochondrial Bioenergetics
por: Ling, Guanjing, et al.
Publicado: (2022)

A Novel Insight into the Cardiotoxicity of Antineoplastic Drug Doxorubicin
por: Heger, Zbynek, et al.
Publicado: (2013)

Biodegradable Polymeric Nanocapsules Prevent Cardiotoxicity of Anti-Trypanosomal Lychnopholide
por: Branquinho, Renata Tupinambá, et al.
Publicado: (2017)

Role of acetylation in doxorubicin-induced cardiotoxicity
por: Li, Daisong, et al.
Publicado: (2021)

Biodegradable Polymeric Nanoparticles for Drug Delivery to Solid Tumors
por: Gagliardi, Agnese, et al.
Publicado: (2021)

Enhancement of oral bioavailability of doxorubicin through surface modified biodegradable polymeric nanoparticles
por: Ahmad, Niyaz, et al.
Publicado: (2018)

INKing the Cardiotoxicity Out of Doxorubicin
por: Guo, Zhen, et al.
Publicado: (2023)

Combat Doxorubicin Cardiotoxicity With the Power of Mitochondria Transfer
por: Wang, Dennis D., et al.
Publicado: (2021)

Bibliometric and visual analysis of doxorubicin-induced cardiotoxicity
por: Lin, Xiaoxiao, et al.
Publicado: (2023)

Protection against Doxorubicin-Induced Cardiotoxicity by Ergothioneine
por: Cheah, Irwin K., et al.
Publicado: (2023)

Potential of exosomes as diagnostic biomarkers and therapeutic carriers for doxorubicin-induced cardiotoxicity
por: Tian, Chao, et al.
Publicado: (2021)

Cardiotoxic drugs Herceptin and doxorubicin inhibit cardiac microvascular endothelial cell barrier formation resulting in increased drug permeability
por: Wilkinson, Emma L., et al.
Publicado: (2016)

Biodegradable Polymeric Microsphere-Based Drug Delivery for Inductive Browning of Fat
por: Jiang, Chunhui, et al.
Publicado: (2015)

Polymeric Micelles of Biodegradable Diblock Copolymers: Enhanced Encapsulation of Hydrophobic Drugs
por: Hussein, Yasser H. A., et al.
Publicado: (2018)

Editorial: Biodegradable polymeric materials in tissue engineering and their application in drug delivery
por: Singh, Sudarshan, et al.
Publicado: (2023)

Hyperhomocysteinaemia Promotes Doxorubicin-Induced Cardiotoxicity in Mice
por: Fan, Rui, et al.
Publicado: (2023)

Dipyridamole ameliorates doxorubicin-induced cardiotoxicity
por: Alyasiry, Esraa, et al.
Publicado: (2022)

Leucine zipper protein 1 prevents doxorubicin-induced cardiotoxicity in mice
por: Fan, Di, et al.
Publicado: (2023)

Nanometronomic treatment of 4T1 breast cancer with nanocaged doxorubicin prevents drug resistance and circumvents cardiotoxicity
por: Mazzucchelli, Serena, et al.
Publicado: (2016)

Targeted Drug Delivery Biopolymers Effectively Inhibit Breast Tumor Growth and Prevent Doxorubicin-Induced Cardiotoxicity
por: Dragojevic, Sonja, et al.
Publicado: (2022)

Low dose radiation prevents doxorubicin-induced cardiotoxicity
por: Jiang, Xin, et al.
Publicado: (2017)

Aptamer–drug conjugate: targeted delivery of doxorubicin in a HER3 aptamer-functionalized liposomal delivery system reduces cardiotoxicity
por: Dou, Xiao-qian, et al.
Publicado: (2018)

Hard polymeric porous microneedles on stretchable substrate for transdermal drug delivery
por: Sadeqi, Aydin, et al.
Publicado: (2022)

Exercise intervention decreases acute and late doxorubicin‐induced cardiotoxicity
por: Wang, Fei, et al.
Publicado: (2021)

Doxorubicin loaded Polymeric Nanoparticulate Delivery System to overcome drug resistance in osteosarcoma
por: Susa, Michiro, et al.
Publicado: (2009)

Isorhamnetin Protects against Doxorubicin-Induced Cardiotoxicity In Vivo and In Vitro
por: Sun, Jing, et al.
Publicado: (2013)

Effect of fermented Cordyceps sinensis on doxorubicin-induced cardiotoxicity in rats
por: Wu, Rong, et al.
Publicado: (2018)

Astragalus polysaccharide restores autophagic flux and improves cardiomyocyte function in doxorubicin-induced cardiotoxicity
por: Cao, Yuan, et al.
Publicado: (2016)

Morphine Enhances Doxorubicin-Induced Cardiotoxicity in the Rat
por: Hole, Lisa Drange, et al.
Publicado: (2014)

The true colors of autophagy in doxorubicin-induced cardiotoxicity
por: Xiao, Bin, et al.
Publicado: (2019)

UVRAG Deficiency Exacerbates Doxorubicin-Induced Cardiotoxicity
por: An, Lin, et al.
Publicado: (2017)

Autophagy and mitophagy in the context of doxorubicin-induced cardiotoxicity
por: Koleini, Navid, et al.
Publicado: (2017)

Telomerase therapy attenuates cardiotoxic effects of doxorubicin
por: Chatterjee, Shambhabi, et al.
Publicado: (2021)

Mitochondrial-Targeted Therapy for Doxorubicin-Induced Cardiotoxicity
por: Wu, Bin Bin, et al.
Publicado: (2022)

Can ARNI Prevent Doxorubicin-Induced Cardiotoxicity?
por: Özgür Barış, Veysel, et al.
Publicado: (2022)

The Essential Strategies to Mitigate Cardiotoxicity Caused by Doxorubicin
por: Chaulin, Aleksey Michailovich
Publicado: (2023)

miR-451 Silencing Inhibited Doxorubicin Exposure-Induced Cardiotoxicity in Mice
por: Li, Jun, et al.
Publicado: (2019)

Antianemia Drug Roxadustat (FG-4592) Protects Against Doxorubicin-Induced Cardiotoxicity by Targeting Antiapoptotic and Antioxidative Pathways
por: Long, Guangfeng, et al.
Publicado: (2020)

Repeated Remote Ischemic Conditioning Reduces Doxorubicin-Induced Cardiotoxicity
por: He, Quan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_btme1ch1au3543r5t2oj2m8b94